Company Filing History:
Years Active: 2006
Title: Inventor Spotlight: Stefan Gabriel Jozef Thoelen
Introduction
Stefan Gabriel Jozef Thoelen, an innovative inventor based in St. Gilles, Belgium, has made significant contributions to the field of vaccine development. With one patent to his name, his work focuses on advancing the efficacy of vaccines against hepatitis.
Latest Patents
Stefan Thoelen is credited with a patent for a novel vaccine composition. This patent details a formulation that includes a hepatitis B antigen combined with aluminium phosphate. Notably, the vaccine compositions may also incorporate an inactivated hepatitis A virus, aluminium hydroxide, and formol. These combined hepatitis A and B vaccine formulations are designed for human administration, utilizing a two-dose regimen, illustrating his ability to develop multifaceted solutions in vaccination.
Career Highlights
Stefan has excelled in his professional journey at SmithKline Beecham Biologicals S.A., contributing to groundbreaking biopharmaceutical research. His work emphasizes the importance of innovation in public health, specifically in the development of safe and effective vaccines.
Collaborations
Throughout his career, Stefan Thoelen has collaborated with notable coworkers, including Claude Artois and Michael J. Clark. These collaborations highlight the importance of teamwork in research and innovation, driving advancements in vaccine technology.
Conclusion
Stefan Gabriel Jozef Thoelen's contributions to vaccine development exemplify the critical role inventors play in enhancing global health. His patent showcases a promising approach to combating hepatitis, reflecting his commitment to innovation in the healthcare sector. As research and development continue to evolve, Thoelen's work will undoubtedly have lasting impacts on vaccine efficacy and patient safety.